Chemical Management

JAGGAER and Chemwatch to Deliver Industry-Leading Chemicals Search and Management Solution

JAGGAER and Chemwatch

JAGGAER, the global leader in Autonomous Commerce, is collaborating with Chemwatch, the international leader in enhanced chemicals management, to enable researchers to comply with safety standards across the full lifecycle for chemical reagents while saving on time and cost. The integration gives users of JAGGAER Research Material Management (RMM), the industry-leading solution for acquiring and managing commercial reagents and lab supplies, access to more than 140 million Chemwatch Safety Data Sheets (SDS).

The integration will be available to mutual customers in Q3 2023. It will enable them to view Safety Data Sheets and use the associated indexed data in real time. “Extending our solutions through partnerships like this is at the heart of our Autonomous Commerce strategy to make customers stronger, faster and more agile while reducing costs and risks,” said JAGGAER Chief Product Officer, Dawn Andre.

Regulations require organizations to maintain a supplier-specific SDS for each chemical in their inventory. While that’s already a significant task for a manufacturing or MRO operation, for even moderately large research labs that often have inventories of more than 50,000 products – and constantly expanding – the challenge becomes truly daunting. Service organizations have been the traditional answer, but with annual charges per document, cost can be a serious barrier.

“The new JAGGAER RMM-Chemwatch integration is highly automated, minimizing manual review and attention, so you get the benefits of the full-service approach at a lower, predictable annual cost,” said Tom Russell, General Manager, RMM Solutions.

“We’ve been aware of Chemwatch for some time now and have watched their evolution to provide the largest and most comprehensive, rigorously maintained collection of supplier-specific content for materials used in research labs. Coupling JAGGAER’s approach to acquisition and material inventory with their data and flexible API offers the opportunity to bring a uniquely new and valuable capability to the market,” Russell added.

“JAGGAER RMM gives researchers a first-class integrated buying experience. Combined with Chemwatch data and our API, researchers can now automate the identification of vendor-specific documents in the full Chemwatch collection, directly from the purchase process. This will inform the full lifecycle for chemical reagents and lab supplies from acquisition through waste, enabling consistent and informed access and reporting, and reducing risk, while saving time and cost,” said Dr. Bernie Bialkower, Principal, Chemwatch.

“The Chemwatch API already offers real-time access to data that RMM customers previously obtained from third-party suppliers. With this in place, we are exploring other ways in which Chemwatch can provide further information and add more value,” Russell concluded.

About Chemwatch

Chemwatch is a world leader in the chemicals management space. With over 30 years’ experience, they specialize in chemical safety across a range of sectors, including education, healthcare, mining, governments and manufacturing. An international company headquartered in Australia, Chemwatch has offices throughout the US, Europe and Asia-Pacific regions. Chemwatch offers their clients access to over 140 million SDS and support in over 90 countries, with access to 50 languages. They also provide a range of other services, including

SDS authoring Chemicals Management SDS management Risk Assessment analysis Asset management via barcode and RFID Chemical regulatory compliance


JAGGAER is leading the Autonomous Commerce revolution, a self-governing B2B commerce experience between buyers, suppliers, things (IoT) and partners. Over $500 billion worth of goods flows frictionlessly through our Enterprise Commerce Network every year. Leveraging AI and machine learning, our intelligent procurement solutions provide enterprise buyers and suppliers smart-match recommendations that align buyer needs with supplier capabilities. Our solutions autonomously execute many of the repetitive, behind-the-scenes tasks required to facilitate enterprise commerce. We are Networked, Intelligent, Comprehensive and Extensible. We are over 1,100 employees strong, all focused on customer success.


Other News
Chemical Management

Danimer Scientific and Chevron Phillips Chemical Expand Collaboration to Include Application Development for Rinnovo™ Polymers

businesswire | September 21, 2023

Danimer Scientific, Inc. a leading next-generation bioplastics company focused on the development and production of biodegradable materials, today announced it is expanding its collaboration with Chevron Phillips Chemical (“CPChem”) to explore development and commercialization of cast extrusion films, blown extrusion films, injection molded parts and rotational molded parts using Rinnovo™ polymers produced in a loop slurry reactor process. Rinnovo™ is a type of polyhydroxyalkanoate (“PHA”) synthesized from lactones produced using Danimer’s proprietary Novo22™ catalyst technology, which can be used in the production of biodegradable alternatives to traditional plastics. The collaboration expands on Danimer and CPChem’s previously announced agreement, in which Danimer is evaluating the use of CPChem’s loop slurry reactor design to develop a continuous reactor system in the manufacturing process for Rinnovo™. Stephen E. Croskrey, chief executive officer of Danimer, said, “Our business relationship with CPChem continues to yield results, and we’re excited for the further opportunities that lie ahead. CPChem’s Research and Technology lab in Bartlesville, Oklahoma, is a premier facility staffed with world-class talent that we believe will accelerate the path toward adoption of Rinnovo™ materials in high-volume applications that will assist in lowering the cost to serve key markets.” Opened in 1950 by Phillips 66, CPChem’s Bartlesville facility contains first-class research equipment allowing for rapid testing of products across various processing conditions. Additionally, the facility’s testing and analytical capabilities provide a more rapid feedback loop, accelerating the development and optimization of resin formulations. “We continue to be excited about the potential of our MarTECH® process technology and related collaborations to advance Danimer’s Rinnovo™, another CPChem initiative that can help accelerate change for a more sustainable future,” said Venki Chandrashekar, CPChem vice president of research and technology. About Danimer Scientific Danimer is a pioneer in creating more sustainable, more natural ways to make plastic products. For more than a decade, its renewable and sustainable biopolymers have helped create plastic products that are biodegradable and compostable and return to nature instead of polluting our lands and waters. Danimer’s technology can be found in a vast array of plastic end products that people use every day. Applications for its biopolymers include additives, aqueous coatings, fibers, filaments, films and injection-molded articles, among others. Danimer holds more than 430 granted patents and pending patent applications in more than 20 countries for a range of manufacturing processes and biopolymer formulations.

Read More

Chemical Management

Syzygy Plasmonics Signs Strategic Investment Agreement with Mitsubishi Heavy Industries

PR Newswire | October 12, 2023

Syzygy Plasmonics announced today that it has reached a strategic investment agreement with Mitsubishi Heavy Industries, Ltd. (MHI), executed through Mitsubishi Heavy Industries America, Inc. (MHIA). The agreement formalizes ties between Syzygy and MHIA, giving the global multinational engineering and manufacturing technology company greater insight into Syzygy's strategic priorities and an opportunity to support Syzygy's business execution plans. "MHIA has been making moves to establish themselves as one of the leaders in the energy transition," said Syzygy Chief Executive Officer Trevor Best. "Formalizing our relationship with them shows their commitment to helping scale cutting edge technology and opens up new avenues for Syzygy and MHIA to work together as we commercialize our industrial decarbonization platform." Syzygy Plasmonics Syzygy Plasmonics is a deep-decarbonization company. It builds reactors that use light instead of heat to electrify chemical manufacturing and power a cleaner, safer world. Utilizing technology licensed from Rice University and advanced engineering, Syzygy is commercializing a universal photocatalytic reactor platform. When powered with renewable electricity, this tunable technology is designed to reduce both cost and emissions from many different chemical reactions. Starting with solutions designed to consume greenhouse gases and produce low- and zero-emissions hydrogen, the company's mission is to create a world where chemicals, fuels, and fertilizer are low cost, carbon neutral, and accessible to everyone. Mitsubishi Heavy Industries Group Mitsubishi Heavy Industries Group is committed to building a business that contributes to realizing a decarbonized society while investing in and collaborating with various partners with innovative technologies. This investment will help Syzygy Plasmonics to accelerate commercialization and continue its development of innovative alternative technologies, particularly those that contribute to the hydrogen ecosystem and CO2 ecosystem. Going forward, MHI will continue to enhance and diversify its solutions portfolio, providing its customers with alternative decarbonization technologies to reach their net zero goals.

Read More

Chemical Management

Sapio Sciences Unifies Small- and Large-Molecule Discovery on a Single Platform

Business Wire | October 10, 2023

Sapio Sciences, the science-aware™ lab informatics platform, today announced the launch of the Sapio Chemistry solution, which unifies small-molecule and large-molecule discovery workflows on a single platform. Built on the same no-code platform as Sapio’s existing large-molecule discovery electronic lab notebook solution, Sapio Chemistry enables scientists to draw insights across all their organization’s discovery experiments. See Sapio’s new Chemistry solution for yourself in this exclusive webinar on October 11, 2023 - register here. “Many organizations are still running decades-old electronic laboratory notebooks (ELNs) and other software for capturing chemical synthesis experiments and registering small molecules,” said Kevin Cramer, president and CEO of Sapio Sciences. “Large-molecule and small-molecule discovery have traditionally been managed on disparate systems, creating artificial islands that impede scientific collaboration and decision-making. Sapio is excited to give biopharma organizations the opportunity to consolidate all their chemistry experiments on a modern, unified lab platform.” Sapio Chemistry is designed to facilitate collaboration among chemistry teams and their colleagues in analytical core facilities and screening labs, including contract research organizations. Advanced, chemically intelligent search built into Sapio Chemistry makes up-to-date project data easily accessible to the entire team. Out-of-the-box, configurable templates simplify the capture and sharing of chemistry experiments, including the reaction, reagents, solvents, and products through to registering synthesized compounds, batches, and lots and requesting assays. Sapio Chemistry also includes advanced capabilities for sample and inventory management, leveraging the strong sample-handling features built into the Sapio platform. Sapio Chemistry includes the latest science-aware™ functionality from Sapio, offering the first-ever lab triple-play solution of ELN, laboratory information management system (LIMS), and Jarvis scientific data cloud all in one. Science-aware means the system unifies data and works the way scientists do with built-in tools for managing, visualizing, and analyzing data to make life in the lab simple. About Sapio Sciences Sapio Sciences' mission is to improve life in the lab — because science is complex, Sapio makes technology simple. Sapio is a global business offering an all-in-one science-aware™ lab informatics platform combining cloud-based LIMS, ELN, and Jarvis data solutions. Sapio serves some of the largest global and niche brands, including biopharma, CROs and clinical diagnostic labs across NGS genomic sequencing, bioanalysis, bioprocessing, stability, clinical, histopathology, drug research, and in vivo studies.

Read More

Chemical Management

LBB Specialties Announces Principal Partnership with Viscofan

PR Newswire | October 25, 2023

LBB Specialties (LBBS), a leader in specialty chemicals and ingredients distribution in North America, announces a new partnership with Viscofan DE, a global leader in collagen manufacturing. LBB Specialties will be Viscofan's preferred partner in the United States for their portfolio of premium collagen hydrolysates, including COLLinstant® and COLLinstant LMW®. "Viscofan has over 90 years of experience in the collagen market. We are excited to bring this expertise to our customer base, as these products meet global consumer demand for highly bioavailable ingredients with a major advantage over traditional collagen formulas," said Mike DeGennaro, Senior Vice President of LBB Specialties Food & Nutrition. Viscofan DE is the center of excellence for collagen products within the Viscofan group. Viscofan applies proprietary technologies and standardized extraction methods to process collagen from bovine skin for the development and industrial-scale production of novel collagen ingredients and biometrics. "LBB Specialties' technical expertise and dedicated commercial team is uniquely positioned to expand our innovative offerings in the US nutraceutical market," said James Murray, Business Manager at Viscofan. "Their existing portfolio of high-quality ingredients for health and wellness applications is the perfect complement to our COLLinstant® product line of collagen peptide alternatives." About LBB Specialties LBB Specialties is a leader in North American specialty chemicals and ingredients. It is a diversified supplier serving end-markets including care, food & nutrition, industrial specialties, and life sciences. LBB Specialties generates approximately $500 million in revenue annually and employs more than 110 commercial team members.

Read More